Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Interest Expenses (2016 - 2023)

Historic Interest Expenses for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to $1.9 million.

  • RedHill Biopharma's Interest Expenses fell 5429.52% to $1.9 million in Q2 2023 from the same period last year, while for Dec 2024 it was $1.9 million, marking a year-over-year decrease of 6010.77%. This contributed to the annual value of $2.1 million for FY2024, which is 7859.45% down from last year.
  • RedHill Biopharma's Interest Expenses amounted to $1.9 million in Q2 2023, which was down 5429.52% from $421000.0 recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Interest Expenses registered a high of $31.8 million during Q3 2022, and its lowest value of $74000.0 during Q2 2019.
  • Over the past 5 years, RedHill Biopharma's median Interest Expenses value was $3.7 million (recorded in 2020), while the average stood at $4.2 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first plummeted by 9569.02% in 2019, then skyrocketed by 483918.92% in 2020.
  • RedHill Biopharma's Interest Expenses (Quarter) stood at $187000.0 in 2019, then soared by 2335.29% to $4.6 million in 2020, then dropped by 19.06% to $3.7 million in 2021, then tumbled by 32.69% to $2.5 million in 2022, then fell by 22.37% to $1.9 million in 2023.
  • Its Interest Expenses stands at $1.9 million for Q2 2023, versus $421000.0 for Q1 2023 and $2.5 million for Q4 2022.